Search Results - Saillard, Jelena

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

    Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia by Vanover, Kimberly E., Davis, Robert E., Zhou, Yun, Ye, Weiguo, Brašić, James R., Gapasin, Lorena, Saillard, Jelena, Weingart, Michal, Litman, Robert E., Mates, Sharon, Wong, Dean F.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    WED-270 Clinical profile of patients considered at-risk for MASH with fibrosis identified through an ongoing global screening program with genetics

    WED-270 Clinical profile of patients considered at-risk for MASH with fibrosis identified through an ongoing global screening program with genetics by Daniels, Samuel, Nelander, Karin, Eriksson, John, Saillard, Jelena, Jermutus, Lutz, Tavaglione, Federica, Raposo, Joao-Filipe, Arrese, Marco, de Guevara, Alma Laura Ladrón, Gentilucci, Umberto Vespasiani, Alkhouri, Naim, Blau, Jenny

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

    Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia by Vanover, Kimberly E, Davis, Robert E, Zhou, Yun, Ye, Weiguo, Brašić, James R, Gapasin, Lorena, Saillard, Jelena, Weingart, Michal, Litman, Robert E, Mates, Sharon, Wong, Dean F

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA

    F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA by Davis, Robert, Dmitrienko, Alex, Glass, Steven, Kozauer, Susan, Saillard, Jelena, Weingart, Michal, Satlin, Andrew, Mates, Sharon, Correll, Christoph, Vanover, Kimberly

    Published in Schizophrenia bulletin
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY

    S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY by Vanover, Kimberly, Dmitrienko, Alex, Glass, Steven, Kozauer, Susan, Saillard, Jelena, Weingart, Michal, Satlin, Andrew, Mates, Sharon, Correll, Christoph, Davis, Robert

    Published in Schizophrenia bulletin
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    S117. FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE IITI-007): RESULTS FROM A 12 MONTH OPEN LABEL SAFETY STUDY FOR LUMATEPERONE IN PATIENTS WITH STABLE SYMPTOMS OF SCHIZOPHRENIA

    S117. FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE IITI-007): RESULTS FROM A 12 MONTH OPEN LABEL SAFETY STUDY FOR LUMATEPERONE IN PATIENTS WITH STABLE SYMPTOMS OF SCHIZOPHREN... by Vanover, Kimberly, Satlin, Andrew, Durgam, Saresh, Weingart, Michal, Saillard, Jelena, Sanchez, Juan, Hossain, Shawon, Glass, Steven, Kozauer, Susan, Mates, Sharon, Davis, Robert

    Published in Schizophrenia bulletin
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    24. The Clinical Development of Lumateperone (ITI-007) for the Treatment of Schizophrenia

    24. The Clinical Development of Lumateperone (ITI-007) for the Treatment of Schizophrenia by Vanover, Kimberly, Correll, Christoph, Dmitrienko, Alex, Glass, Steve, O’Gorman, Cedric, Saillard, Jelena, Weingart, Michal, Mates, Sharon, Davis, Robert

    Published in Schizophrenia bulletin
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study

    30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study by Vanover, Kimberly, Glass, Steven, Kozauer, Susan, Saillard, Jelena, Sanchez, Juan, Weingart, Michal, Mates, Sharon, Satlin, Andrew, Davis, Robert

    Published in CNS spectrums
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: